RT @EricTopol: New @NEJM #ACC21 What's the right dose of aspirin for people with heart disease? A large randomized trial with a lot of cro…
RT @EricTopol: New @NEJM #ACC21 What's the right dose of aspirin for people with heart disease? A large randomized trial with a lot of cro…
wondering about the optimal dose of aspirin for #patients with #heart disease? just presented at #ACC21 with the ADAPTABLE Trial. no difference in a #crossover #randomized trial between 81 vs 325 mg. see full report 👇https://t.co/OmhtJwZ4wD #ACCEarlyCa
Lessons from the #ADAPTABLE trial: If you involve patients and ask them to self-randomize, they'll do it with enthusiasm. But then a good part of them will do what they like, making the trial results unreliable. #ACC21 https://t.co/2ATYuZlFmS
RT @EricTopol: New @NEJM #ACC21 What's the right dose of aspirin for people with heart disease? A large randomized trial with a lot of cro…
RT @EricTopol: New @NEJM #ACC21 What's the right dose of aspirin for people with heart disease? A large randomized trial with a lot of cro…
RT @FudimMarat: ⚡️ADAPTABLE Results presented ⚡️ @schuyler_jones @DCRINews @PCORnetwork @texhern @manesh_patelMD @ACCinTouch #ACC21 ➡️15,…
⚡️ADAPTABLE Results presented ⚡️ @schuyler_jones @DCRINews @PCORnetwork @texhern @manesh_patelMD @ACCinTouch #ACC21 ➡️15,000 patients randomized. Aspirin 81 vs 325mg No significant difference in safety or effectiveness https://t.co/uCjE49yOx7 https://t